Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
Small Cap Shares
Catch 'em before it's too late: 3 ASX small-cap shares that just started soaring
Share Market News
5 ASX 300 directors buying up their company shares in the past week
Why Estia Health, GQG, GUD, and Pilbara Minerals shares are storming higher
Mergers & Acquisitions
Why is this ASX 300 healthcare share charging 9% higher today?
Share Market News
Returning capital: These ASX companies have been buying back their shares in 2023
Why Estia Health, Graincorp, Novonix, and Polynovo shares are racing higher
3 ASX All Ords shares rocketing over 10% on big news
Why this fund manager thinks these 2 outperforming ASX shares can keep beating the market
'Attractive valuations': 2 ASX shares to buy now before they explode
Why Core Lithium, Estia Health, Kingsgate, and St Barbara shares are charging higher
Mergers & Acquisitions
Estia Health share price jumps 21% on takeover approach
I think value investors would love to buy these 2 cheap ASX shares
Yes, Estia Health has historically paid two fully franked shareholder dividends a year.
Estia Health generally pays its shareholder dividends in March and September.
Yes, Estia Health has a dividend reinvestment plan (DRP) which allows eligible shareholders to invest all or part of their dividend payments into additional fully paid shares. The extent to which the DRP applies to future dividends is included as part of each dividend announcement.
Estia Health Ltd listed on the ASX on 5 December 2014.
|25 Aug 2023||$0.1200||100.00%||Final||15 Sep 2023|
|24 Feb 2023||$0.0370||100.00%||Interim||17 Mar 2023|
|25 Feb 2022||$0.0235||100.00%||Interim||18 Mar 2022|
|27 Aug 2021||$0.0230||100.00%||Final||17 Sep 2021|
|28 Feb 2020||$0.0540||100.00%||Interim||27 Mar 2020|
|04 Sep 2019||$0.0780||100.00%||Final||02 Oct 2019|
|05 Mar 2019||$0.0800||100.00%||Interim||27 Mar 2019|
|06 Sep 2018||$0.0800||100.00%||Final||28 Sep 2018|
|01 Mar 2018||$0.0780||100.00%||Interim||23 Mar 2018|
|07 Sep 2017||$0.0000||100.00%||Final||29 Sep 2017|
|30 Sep 2016||$0.1280||100.00%||Final||07 Nov 2016|
|22 Mar 2016||$0.1280||100.00%||Interim||20 Apr 2016|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Estia Health Ltd (ASX: EHE) operates residential aged care facilities in Australia. The company has more than 70 facilities in Victoria, South Australia, New South Wales, and Queensland. Estia's facilities provide accommodation, clinical care, and daily living services for around 8,000 residents. The company's clinical care services include 24-hour nursing care, personal care, wound management, administering pharmaceuticals, physiotherapy, and occupational therapy. Federal government funding makes up the majority of Estia's total revenue.
|04 Dec 2023||$3.07||$-0.01||-0.32%||574,196||$3.08||$3.08||$3.07|
|01 Dec 2023||$3.08||$0.01||0.33%||523,746||$3.07||$3.08||$3.07|
|30 Nov 2023||$3.07||$0.00||0.00%||888,427||$3.07||$3.08||$3.07|
|29 Nov 2023||$3.07||$0.02||0.66%||1,738,899||$3.07||$3.08||$3.07|
|28 Nov 2023||$3.05||$0.00||0.00%||207,068||$3.05||$3.06||$3.05|
|27 Nov 2023||$3.05||$0.00||0.00%||383,114||$3.05||$3.06||$3.05|
|24 Nov 2023||$3.05||$0.00||0.00%||473,964||$3.06||$3.06||$3.05|
|23 Nov 2023||$3.05||$0.00||0.00%||535,154||$3.06||$3.06||$3.05|
|22 Nov 2023||$3.05||$-0.01||-0.33%||663,172||$3.06||$3.06||$3.05|
|21 Nov 2023||$3.06||$0.01||0.33%||859,600||$3.05||$3.06||$3.05|
|20 Nov 2023||$3.05||$0.00||0.00%||708,152||$3.06||$3.06||$3.05|
|17 Nov 2023||$3.05||$0.00||0.00%||8,217,820||$3.05||$3.06||$3.05|
|16 Nov 2023||$3.05||$0.00||0.00%||699,520||$3.05||$3.06||$3.05|
|15 Nov 2023||$3.05||$0.00||0.00%||1,241,649||$3.05||$3.06||$3.04|
|14 Nov 2023||$3.05||$-0.01||-0.33%||786,954||$3.05||$3.06||$3.04|
|13 Nov 2023||$3.06||$0.01||0.33%||2,993,455||$3.04||$3.06||$3.04|
|10 Nov 2023||$3.05||$-0.01||-0.33%||2,009,759||$3.06||$3.06||$3.02|
|09 Nov 2023||$3.06||$0.00||0.00%||370,527||$3.06||$3.06||$3.05|
|08 Nov 2023||$3.06||$0.00||0.00%||455,244||$3.06||$3.06||$3.05|
|07 Nov 2023||$3.06||$0.01||0.33%||818,499||$3.05||$3.06||$3.05|
|24 Aug 2023||Sean Bilton||Exercise||343,261||$1,070,974||
Conversion of securities. 590,594 LTI Performance Rights
|24 Aug 2023||Sean Bilton||Buy||343,261||$1,070,974||
Conversion of securities.
|02 Mar 2023||Karen Penrose||Buy||7,238||$14,982||
|24 Feb 2023||Gary Weiss||Buy||25,000||$51,750||
|Dr Gary Hilton Weiss||Non-Executive DirectorNon-Executive Chairman||Feb 2016||
Mr Weiss has international business experience and has been involved in numerous cross-border mergers and acquisitions. Gary is Chairman of Cromwell Property Group Limited and Ardent Leisure Group Limited, Executive Director of Ariadne Australia Limited, and a Director of Thorney Opportunities Limited and Hearts and Minds Investments Limited. Gary is also a Commissioner of the Australian Rugby League Commission and a Director of the Victor Chang Cardiac Research Institute. Gary was Chairman of Coats Group plc from May 2004 to April 2012, Chairman of Clearview Wealth Ltd from 2013 to May 2016, Chairman of Ridley Corporation from June 2015 to June 2020, Executive Director of Guinness Peat Group plc from 1990 to April 2011 and has held directorships of numerous companies, including The Straits Trading Co Limited, Tag Pacific Limited, Pro-Pac Packaging Limited, Premier Investments Ltd, Westfield Group, Tower Australia Limited, Australian Wealth Management Limited, Tyndall Australia Limited, Joe White Maltings Limited, CIC Limited, Whitlam Turnbull & Co Limited and Industrial Equity Limited. Gary has authored numerous articles on a variety of legal and commercial topics. Gary was awarded a Member of the Order of Australia (AM) in recognition of his significant services to business and to the community.
|Ms Helen Kurincic||Non-Executive Director||Jul 2017||
Ms Kurincic has executive and non-executive experience across the healthcare sector. Helen is Chairman of Integral Diagnostics Limited and McMillan Shakespeare Limited, and a Non-executive Director of HBF Health Limited. Helen was previously the Chief Operating Officer and Director of Genesis Care for seven years from early inception in 2007, creating Australia's largest radiation oncology and cardiology service business. Previous roles also include Non-executive Director of Sirtex Medical Limited, Non-executive Director of DCA Group Limited which included residential aged care in Australia and New Zealand, Non-executive Director of AMP Capital Investor's aged care business Domain Principal Group, CEO and Executive Director of residential aged care provider Benetas and Board member of Melbourne Health and Orygen Research Centre. Helen has also been actively involved in government policy reform across various areas of the healthcare sector.
|Ms Karen Lee Collett Penrose||Non-Executive Director||Oct 2018||
Ms Penrose is an experienced Company Director who has served as a full-time Non-executive Director since 2014 on the boards of ASX listed companies across the financial services, aged care, healthcare, resources and infrastructure sectors. Karen's executive career was in leadership and CFO roles, mainly in financial services. Karen worked with CBA and HSBC for over 20 years. She is Board and Governance 16 Estia Health | 2022-23 Annual Report 2022-23 Annual Report | Estia Health 17 About this report Chairman and CEO's Review Key Highlights About Estia Health Board and Governance Corporate Governance Executive Leadership Team COVID-19 Sustainability Risk Management Tax Transparency Report Annual Financial Report about consumer outcomes, financial management and well-versed in operating in a rapidly changing regulatory environment. Karen is a Director and Chair of the Audit Committee of Bank of Queensland, Ramsay Health Care and Cochlear. She is also Director of Marshall Investments Pty Ltd and Rugby Australia Limited. Karen was formally a director of Vicinity Centres, Future Generation Global Investment Company Limited, AWE Limited and Spark Infrastructure Group Limited. Karen is a member of Chief Executive Women.
|Ms Norah Kathleen Barlow||Non-Executive Director||Nov 2014||
Ms Barloe is amongst Australasia's experienced executives and directors, with an in-depth knowledge of the aged and health care sector. Norah also holds experience as the highly respected former CEO and former Director of Summerset Group, an NZX and ASX-listed company named Australasia's best retirement village operator for four years running. Norah has a strong background across business leadership and management, strategy, corporate finance, governance, tax and accounting. Norah was President of the Retirement Villages Association (NZ) for seven years and made an Officer of the New Zealand Order of Merit for services to business in 2014. Norah was also a Non-executive Director of Ingenia Communities Group, Evolve Education Group Limited, and chair of the Audit Committee for Methven Limited. Norah stepped down as CEO of Estia Health in November 2018 and remains on the board as a Non-executive Director. Norah is currently Chief Executive of Heritage Lifecare Limited.
|Mr Paul Foster||Non-Executive Director||Feb 2016||
Mr Foster is an experienced Financial Services professional and Company Director, with more than 20 years of investment experience in the infrastructure, private equity and real estate asset classes, including substantial investments in the healthcare sector. Paul is a Managing Director at Pacific Equity Partners, one of Australia's largest alternative investment management firms. He is also a Director of PEP Services Pty Ltd and PEP Advisory Services Pty Ltd. Paul was a Director of the Opal Aged Care Group between 2010 and 2015 and was Chairman of the Group in 2011. Paul was head of AMP Capital's Infrastructure investment business in Australia and New Zealand until 2015. Before AMP Capital, he was an investment professional at Macquarie Group and Perpetual Investments.
|Mr Sean Bilton||Chief Executive OfficerManaging Director||Jul 2022||
Mr Bilton was previously in the roles of Chief Operating Officer and Deputy CEO since October 2018. Sean has also overseen the successful commissioning of three new homes and consideration of future growth opportunities. His success in leading the company through an unprecedented and complex period of change during the COVID-19 pandemic and the Aged Care Royal Commission ensured Estia Health's continued standing in the sector. During his tenure, Sean has worked closely with the Chief People Officer on the development and operationalisation of Estia Health's employee attraction and retention strategy. Sean has worked for more than 15 years in the sector, his involvement commencing as an Asset Manager at AMP Capital where he managed the integration of multiple acquisitions, which were the genesis of the Opal Healthcare business. When joining Opal as the Head of Commercial in 2010, Sean was responsible for overseeing the acquisition and development led growth of the business, as well as customer acquisition, communications, and marketing.
|Professor Simon Willcock||Non-Executive Director||Sep 2022||
Mr Willcock was appointed to the Board on 1 September 2022. He is a General Practitioner and the Director of Primary Care and wellbeing at MQ Health. He was previously Head of the Discipline of General Practice in the University of Sydney Medical Program. Simon trained as a rural procedural GP and practiced in Inverell, NSW for seven years. For the past thirty years he has worked in academic and clinical practice in Sydney and has had a number of educational leadership roles. Simon was until recently an elected board member and Chair of the Avant Mutual Group and is currently an elected board member and Deputy Chair of the Sydney North Health Network.
|Ms Leanne Ralph||Company Secretary||Apr 2019||
|Steve Lemlin||Chief Financial Officer||
|Damian Hiser||Chief Operating Officer||
|Leanne Ralph||Company Secretary||
|Citicorp Nominees Pty Limited||60,041,234||23.11%|
|J P Morgan Nominees Australia Pty Limited||43,761,862||16.84%|
|Hsbc Custody Nominees (Australia) Limited||43,263,097||16.65%|
|National Nominees Limited||22,533,849||8.67%|
|Bnp Paribas Noms Pty Ltd <Drp>||12,407,006||4.77%|
|Argo Investments Limited||10,809,250||4.16%|
|Hsbc Custody Nominees (Australia) Limited A/C 2||5,079,719||1.96%|
|Hsbc Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C>||4,529,998||1.74%|
|Neweconomy.Com.Au Nominees Pty Limited <900 Account>||4,451,693||1.71%|
|Emalyn Holdings Pty Limited <John Kennedy A/C>||4,102,766||1.58%|
|Mrs Julia Michelle Manken & Mr Mike Darren Manken & Miss Jessica Kelly Manken||2,135,000||0.82%|
|Mr Mark Edward Kennedy <Mark Edward Kennedy A/C>||1,910,678||0.74%|
|Pacific Custodians Pty Limited <Ehe Emp Sub Register>||1,593,513||0.61%|
|Skip Enterprises Pty Ltd <Farquhar A/C>||1,442,768||0.56%|
|Mark Edward Kennedy <Mark Edward Kennedy Family>||1,277,438||0.49%|
|Kennbros Pty Limited||1,156,834||0.45%|
|Riviera Health Pty Ltd <Manken Family Super A/C>||864,750||0.33%|
|Custodial Services Limited <Beneficiaries Holding A/C>||612,724||0.24%|
|Citicorp Nominees Pty Limited <Colonial First State Inv A/C>||600,459||0.23%|
|Mr Ian Ronald Thorley||584,326||0.22%|